REPORTS

Global Smart Inhalers Market Size study, by product (inhalers and nebulizers), Indication (COPD and asthma), End-user (patients and R&D) and Regional Forecasts 2018-2025.

Publishing Date : 14 Feb 2019 Report Code : Bizwit_1770 Pages : 200 Category : Healthcare and Pharma
Description

Global Smart Inhalers Market to reach USD 829.3 Million by 2025. Global smart inhalers market is valued at approximately USD 16.4 Million in 2017 and is anticipated to grow with a healthy growth rate of more than 63.3 % over the forecast period 2018-2025. Technological advancements in smart inhalers is the major trend that are responsible for the wide adoption of smart inhalers globally. Global smart inhalers market is mainly driven by rising prevalence of respiratory diseases such as asthma and COPD. According to WHO, over 90 % of COPD (Chronic obstructive pulmonary disease) observed in middle- & low-income countries. The prevalence of COPD and asthma is rising due to several reasons such as growing consumption of tobacco and cigarettes, rising aging population and growth of air pollutants. The prevalence rate of COPD is high in the United States. COPD is the third leading cause of death in the United States. Further, according to the Asthma Organization UK, in 2015 around 5.4 million people in United Kingdom are presently receiving asthma treatment out of which 4.3 million are adults and rest 1.1 million are children. Moreover, in United Kingdom one in every 11 people is suffering from asthma. This clearly states that there is high prevalence of respiratory diseases positively affects the demand for the smart inhalers. However, lower acceptance in emerging economies is the major factor that impede the growth of global smart inhalers market. On the basis of segmentation, the smart inhalers market is segmented into product, indication and end-user. The product segment of global smart inhalers market is classified into inhalers and nebulizers of which inhalers dominates the major as inhalers are preferred as first option of treatment, portability. Based on indication, the smart inhalers market is classified into asthma and COPD. On the basis of end-user, the market is classified into patients and research & development. The regional analysis of smart inhalers market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America have occupied major share in the global smart inhalers market. The major reasons for the dominance of North America are high awareness regarding asthma and COPD treatment, high technological innovations in healthcare sector, high adoption of smart inhaler device and growing adoption of IOT in healthcare industry. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to growing population affected with respiratory diseases due to rising air pollution. The leading market players mainly include- ? Teva Pharmaceuticals Industries Ltd ? Vectura Group PLC ? AstraZeneca PLC ? Boehringer Ingelheim Gmbh ? Propeller Health ? Cohero Health LLC ? Adherium Limited ? Novartis AG ? Glaxo SmithKine PLC ? OPKO Health The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Product: ? Inhalers o Metered Dose Inhalers o Dry powder inhalers ? Nebulizers By Indication: ? Asthma ? COPD By end-user: ? Patients ? R&D By Regions: ? North America o U.S. o Canada ? Europe o UK o Germany o ROE ? Asia Pacific o China o India o Japan o ROAPEC ? LAMEA o Brazil o Mexico ? ROW o Middle East & Africa Furthermore, years considered for the study are as follows: Historical year - 2015, 2016 Base year - 2017 Forecast period - 2018 to 2025 Target Audience of the Global Smart Inhalers Market in Market Study: ? Key Consulting Companies & Advisors ? Large, medium-sized, and small enterprises ? Venture capitalists ? Value-Added Resellers (VARs) ? Third-party knowledge providers ? Investment bankers ? Investors

Table of Figures

TABLE OF CONTENTS Chapter 1. Global Smart Inhalers Market Definition and Scope 1.1. Research Objective 1.2. Market Definition 1.3. Scope of The Study 1.4. Years Considered for The Study 1.5. Currency Conversion Rates 1.6. Report Limitation Chapter 2. Research Methodology 2.1. Research Process 2.1.1. Data Mining 2.1.2. Analysis 2.1.3. Market Estimation 2.1.4. Validation 2.1.5. Publishing 2.2. Research Assumption Chapter 3. Executive Summary 3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion) 3.2. Key Trends Chapter 4. Global Smart Inhalers Market Dynamics 4.1. Growth Prospects 4.1.1. Drivers 4.1.2. Restraints 4.1.3. Opportunities 4.2. Industry Analysis 4.2.1. Porter's 5 Force Model 4.2.2. PEST Analysis 4.2.3. Value Chain Analysis 4.3. Analyst Recommendation & Conclusion Chapter 5. Global Smart Inhalers Market, By Product 5.1. Market Snapshot 5.2. Market Performance - Potential Model 5.3. Global Smart Inhalers Market, Sub Segment Analysis 5.3.1. Inhalers 5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.3.1.3. Market sub-segments 5.3.1.3.1. Metered Dose Inhalers 5.3.1.3.2. Dry powder inhalers 5.3.2. Nebulizers 5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 6. Global Smart Inhalers Market, By Indication 6.1. Market Snapshot 6.2. Market Performance - Potential Model 6.3. Global Smart Inhalers Market, Sub Segment Analysis 6.3.1. COPD 6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 6.3.2. Asthma 6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 7. Global Smart Inhalers Market, By End-user 7.1. Market Snapshot 7.2. Market Performance - Potential Model 7.3. Global Smart Inhalers Market, Sub Segment Analysis 7.3.1. Patients 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.2. R&D 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 8. Global Smart Inhalers Market, by Regional Analysis 8.1. Smart Inhalers Market, Regional Market Snapshot (2015-2025) 8.2. North America Smart Inhalers Market Snapshot 8.2.1. U.S. 8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.2.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.2.1.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.2.2. Canada 8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.2.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.2.2.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3. Europe Smart Inhalers Market Snapshot 8.3.1. U.K. 8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.1.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.2. Germany 8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.2.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.3. Rest of Europe 8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.3.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.3.3.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4. Asia Smart Inhalers Market Snapshot 8.4.1. China 8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.1.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.2. India 8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.2.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.3. Japan 8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.3.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.3.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.4. Rest of Asia Pacific 8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.4.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.4.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.5. Latin America Smart Inhalers Market Snapshot 8.5.1. Brazil 8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.5.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.5.1.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.5.2. Mexico 8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.5.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.5.2.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.6. Rest of The World 8.6.1. Middle East and Africa 8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.6.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.6.1.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 9. Competitive Intelligence 9.1. Company Market Share (Subject to Data Availability) 9.2. Top Market Strategies 9.3. Company Profiles 9.3.1. Teva Pharmaceuticals Industries Ltd 9.3.1.1. Overview 9.3.1.2. Financial (Subject to Data Availability) 9.3.1.3. Product Summary 9.3.1.4. Recent Developments 9.3.2. Vectura Group PLC 9.3.3. AstraZeneca PLC 9.3.4. Boehringer Ingelheim Gmbh 9.3.5. Propeller Health 9.3.6. Cohero Health LLC 9.3.7. Adherium Limited 9.3.8. Novartis AG 9.3.9. Glaxo SmithKine PLC 9.3.10. OPKO Health